Israel equities closed higher on Thursday, with the blue-chip TA 35 registering a 0.37% gain at the market close. Sector-level strength in Oil & Gas, Banking and Biomed contributed to the rise in the headline index.
Among individual components, Newmed Energy LP (TASE:NWMDp) was the top performer on the TA 35, climbing 5.52% - a 93.00-point increase - to finish at 1,777.00. Next Vision Stabilized Systems (TASE:NXSN) added 3.86%, or 720.00 points, closing at 19,360.00. Teva Pharmaceutical Industries Ltd (TASE:TEVA) rose 3.18%, or 430.00 points, to end the day at 13,970.00.
On the downside, Palo Alto Networks Inc (TASE:CYBR) posted the largest drop among TA 35 constituents, falling 4.46% or 4,750.00 points to close at 101,850.00. Menora Mivtachim Holdings Ltd (TASE:MMHD) declined 3.66%, a 1,880.00-point fall to 49,450.00, while Harel (TASE:HARL) lost 3.12% or 580.00 points to finish at 18,030.00.
Market breadth on the Tel Aviv Stock Exchange was negative at the session close, with 285 stocks declining, 179 advancing and 92 finishing unchanged.
Teva Pharmaceutical shares moved to five-year highs during the session, advancing 3.18% to 13,970.00.
Commodities and currency moves accompanied equity trading. U.S. crude for December delivery rose 0.09%, up $0.08 to $86.61 a barrel. Brent crude for January delivery advanced 0.88%, an increase of $0.82, to $93.58 a barrel. By contrast, the December gold futures contract fell 3.13%, a decline of $125.35, to trade at $3,875.15 per troy ounce.
In currency markets, the U.S. dollar strengthened against the shekel, with USD/ILS up 0.66% to 3.20. The euro also rose versus the shekel, with EUR/ILS up 0.40% to 3.53. U.S. Dollar Index futures were quoted up 0.25% at 103.07.
This session combined selective sector leadership with uneven breadth: a handful of large gains among oil and healthcare-related names alongside several notable declines in financial and cybersecurity-related stocks.